Head and Neck Squamous Cell Carcinoma Clinical Trials in Frankfurt am Main
3 recruitingFrankfurt am Main, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 3
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
Recurrent Head and Neck Squamous Cell Carcinoma
Universität des Saarlandes214 enrolled18 locationsNCT07026474
Recruiting
Phase 2Phase 3
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE350 enrolled189 locationsNCT04534205
Recruiting
Not Applicable
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
Head and Neck Squamous Cell Carcinoma
Technische Universität Dresden304 enrolled10 locationsNCT03396718